Nexien BioPharma, Inc. (NXEN)
- Previous Close
0.0163 - Open
0.0163 - Bid --
- Ask --
- Day's Range
0.0163 - 0.0210 - 52 Week Range
0.0110 - 0.1000 - Volume
30,225 - Avg. Volume
10,755 - Market Cap (intraday)
1.417M - Beta (5Y Monthly) 1.65
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings Date May 15, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Nexien BioPharma, Inc. focuses on the formulation, development, and commercialization of cannabinoid-based pharmaceuticals, drug delivery systems, and related technologies for diseases, disorders, and medical conditions. The company was formerly known as Intiva BioPharma Inc. and changed its name to Nexien BioPharma, Inc. in September 2018. Nexien BioPharma, Inc. is based in Glendale, Colorado.
www.nexienbiopharma.com--
Full Time Employees
June 30
Fiscal Year Ends
Sector
Recent News: NXEN
Performance Overview: NXEN
Trailing total returns as of 5/15/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NXEN
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NXEN
Valuation Measures
Market Cap
1.10M
Enterprise Value
1.33M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-330.90%
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-272.87k
Diluted EPS (ttm)
-0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
2.62k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
11.46k
Research Analysis: NXEN
Company Insights: NXEN
NXEN does not have Company Insights